Clinical Trial Update: Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated safety, tolerability, and immunogenicity of Moderna's mRNA-1325 vaccine in healthy adults for Zika virus disease; the study is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zika Virus Disease

Drugs mentioned

• mRNA-1325

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Zika Virus | Phase 1 | Status: COMPLETED | Results posted: 2024-06-17